Fixed-dose lercanidipine/enalapril for hypertension.

Author: HallerHermann, MenneJan

Paper Details 
Original Abstract of the Article :
The dihydropyridine calcium channel blocker lercanidipine and the ACE inhibitor enalapril are frequently used in the treatment of hypertensive patients. In April 2007, a fixed-dose combination of the two drugs was approved in Germany for the treatment of patients not responding to monotherapy. It is...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1358/dot.2008.44.4.1164756

データ提供:米国国立医学図書館(NLM)

Fixed-Dose Lercanidipine/Enalapril for Hypertension: A Combined Approach

Hypertension, or high blood pressure, is like a relentless desert wind, putting undue strain on the cardiovascular system. Researchers are constantly seeking effective ways to manage this condition, and combining different medications is a strategy often explored. This review focuses on a fixed-dose combination of lercanidipine and enalapril, two medications commonly used to treat hypertension.

The review examines the effectiveness and safety of combining these two drugs, seeking to determine if this synergistic approach could be a more effective solution for patients struggling with hypertension.

A New Oasis in the Desert of Hypertension

The fixed-dose combination of lercanidipine and enalapril has shown a stronger blood pressure-lowering effect than monotherapy with either drug alone. This combined approach may offer a more effective and convenient option for patients managing their hypertension.

Navigating the Desert of Hypertension

The review emphasizes the importance of individualized treatment approaches and careful monitoring of side effects. While this combination holds promise for managing hypertension, patients should work closely with their doctors to determine the best treatment strategy for their individual needs.

Dr.Camel's Conclusion

This review explores the potential of combining lercanidipine and enalapril for hypertension, suggesting that this strategy could offer a more effective solution for some patients. It reminds us that managing hypertension is a journey through a vast desert, and finding the right oasis of treatment involves careful consideration of individual needs and ongoing monitoring.

Date :
  1. Date Completed 2008-08-07
  2. Date Revised 2019-11-10
Further Info :

Pubmed ID

18536784

DOI: Digital Object Identifier

10.1358/dot.2008.44.4.1164756

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.